ViewPoint Therapeutics
San Francisco
About ViewPoint Therapeutics
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts. The company's crystallin stabilizers include a small molecule that is active in preclinical models of age-related cataracts via a target-based screening and optimization effort, providing physicians with drugs to prevent or reverse protein misfolding, which is implicated in numerous common disorders of aging including cataracts, presbyopia, and neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $39.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2018)
- Website: viewpointtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/viewpoint-therapeutics-56428 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.